Biomimetic nanoparticle technology for cardiovascular disease detection and treatment
Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …
Ebselen: prospective therapy for cerebral ischaemia
Stroke occurs due to haemorrhage or occlusive injury and results in ischaemia and
reperfusion injury. A variety of destructive mechanisms are involved including oxygen …
reperfusion injury. A variety of destructive mechanisms are involved including oxygen …
[HTML][HTML] Results of systematic review of research on diagnosis and treatment of coronary heart disease in women: Summary
D Grady, L Chaput, M Kristof - AHRQ Evidence Report Summaries, 2003 - ncbi.nlm.nih.gov
Coronary heart disease (CHD) is the most common disease and cause of death in women,
accounting for over 250,000 deaths in women per year. Over the last two decades, multiple …
accounting for over 250,000 deaths in women per year. Over the last two decades, multiple …
急性心肌梗死的治疗进展
薛冰 - 中国实用医药, 2010 - cqvip.com
急性心肌梗死的治疗进展-[维普官方网站]-www.cqvip.com-维普网 我的维普 购物车 充值 客服
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 您的 …
首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议平台 | 学术机构 您的 …
Design and production of new chimeric reteplase with enhanced fibrin affinity: a theoretical and experimental study
E Mohammadi, K Mahnam… - Journal of …, 2021 - Taylor & Francis
Plasminogen activators (PAs) are widely used for treatment of disorders caused by clot
formation. Fibrin specific PAs are safe drugs from this group because of reducing the …
formation. Fibrin specific PAs are safe drugs from this group because of reducing the …
尿激酶溶栓加阿司匹林联合氯吡格雷治疗急性心肌梗死的疗效观察
孙玉平， 许建新 - 中国社区医师: 医学专业, 2012 - cqvip.com
目的: 观察尿激酶溶栓加阿司匹林联合氯吡格雷治疗急性心肌梗死有效性及安全性. 方法: 70
例急性心肌梗死患者随机分为对照组与治疗组各35 例, 两组首先都采用常规阿司匹林联合氯吡 …
例急性心肌梗死患者随机分为对照组与治疗组各35 例, 两组首先都采用常规阿司匹林联合氯吡 …
急性心肌梗死药物溶栓治疗研究概况
刘贵富 - 蛇志, 2014 - cqvip.com
急性心肌梗死发病突然, 发展迅速, 病死率高, 因此, 积极, 合理, 快速, 准确, 有效的采取应对措施
才能降低急性发作期患者的病死率及预后. 有研究证明, 急性心肌梗死死亡患者中50 …
才能降低急性发作期患者的病死率及预后. 有研究证明, 急性心肌梗死死亡患者中50 …
Possible mechanism for nitric oxide and oxidative stress induced pathophysiological variance in acute myocardial infarction development: a study by a flow injection …
D Yao, AG Vlessidis, NP Evmiridis, S Siminelakis… - Analytica chimica …, 2004 - Elsevier
The acute myocardial infarction (AMI) model was established through rabbits, and this kind
of model was used to investigate the possible mechanism for the AMI mediated damage …
of model was used to investigate the possible mechanism for the AMI mediated damage …
溶栓药物在急性心肌梗死治疗的应用进展
郝志敏， 马静， 黄贤胜 - 承德医学院学报, 2009 - cqvip.com
溶栓药物在急性心肌梗死治疗的应用进展-[维普官方网站]-www.cqvip.com-维普网 我的维普
购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议 …
购物车 充值 客服 首页 | 期刊大全 | 文献分类 | 优先出版 | 论文检测 | 论文选题 | 在线分享 | 会议 …
Tissue plasminogen activator for blocked peritoneal dialysis catheters
RG Krishnan, NE Moghal - Pediatric Nephrology, 2006 - Springer
Tissue plasminogen activator for blocked peritoneal dialysis catheters Page 1 Pediatr Nephrol
(2006) 21:300 DOI 10.1007/s00467-005-2070-y LETTER TO THE EDITORS RG Krishnan · NE …
(2006) 21:300 DOI 10.1007/s00467-005-2070-y LETTER TO THE EDITORS RG Krishnan · NE …